Haleon (HLN) Cash from Investing Activities Growth (1y) (2022 - 2023)

Haleon (HLN) Cash from Investing Activities Growth (1y) (2022 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 13.93%
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 57.14%
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -186.78%
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 551.55%
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 526.11%
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -3,664.79%
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -3.45%
10 Vireo Growth 10.51 Bn 10.36 Bn 59.30 Mn 827.27%

Historic Data

Download Data
DateValue
Dec 31, 2023 97.68%
Dec 31, 2022 -1,713.76%